Clinical Trial Update: A Randomized, Sham-controlled Study of gammaCore ® (nVNS) for Prevention of Episodic Migraine [NA]

View source ↗

Summary

A randomized, sham-controlled trial evaluating gammaCore (nVNS) for the prevention of episodic migraine has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• gammaCore

Snippet

Sponsor: ElectroCore INC | Conditions: Migraine | NA | Status: COMPLETED | Results posted: 2019-08-19